Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SCIDaR (Solina Centre for International Development and Research), founded in 2017 as an affiliate of the Solina Group, accelerates positive health, social, and economic reforms through high-quality program design/implementation, capacity building, scientific research, knowledge generation, agenda-setting and stakeholder convening. It operates primarily in Nigeria but has expanded to several West and Central African countries. Its work focuses on improving outcomes for disadvantaged populations via tailored public health interventions such as immunization campaigns (e.g., polio eradication), maternal health initiatives (e.g., postpartum hemorrhage prevention), education reform support in Liberia, among others[1][2][5].
The organization does not develop drugs or biologics but rather implements large-scale public health programs with governments and international partners.
No clinical results or pipeline data are available since it does not conduct therapeutic R&D.Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SCIDaR.